These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 8636110

  • 1. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
    Kobayashi K, Oka K, Forte T, Ishida B, Teng B, Ishimura-Oka K, Nakamuta M, Chan L.
    J Biol Chem; 1996 Mar 22; 271(12):6852-60. PubMed ID: 8636110
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E, Kobayashi K, Tzung KW, Li L, Fuke Y, Chan L.
    Hum Gene Ther; 1997 Nov 01; 8(16):1921-33. PubMed ID: 9382958
    [Abstract] [Full Text] [Related]

  • 3. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [Abstract] [Full Text] [Related]

  • 4. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
    Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J.
    J Clin Invest; 1993 Aug 01; 92(2):883-93. PubMed ID: 8349823
    [Abstract] [Full Text] [Related]

  • 5. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS, Martins I, Davidson BL.
    J Gene Med; 2000 Aug 01; 2(1):41-51. PubMed ID: 10765504
    [Abstract] [Full Text] [Related]

  • 6. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
    Nomura S, Merched A, Nour E, Dieker C, Oka K, Chan L.
    Gene Ther; 2004 Oct 01; 11(20):1540-8. PubMed ID: 15269711
    [Abstract] [Full Text] [Related]

  • 7. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1).
    Teng B, Ishida B, Forte TM, Blumenthal S, Song LZ, Gotto AM, Chan L.
    Arterioscler Thromb Vasc Biol; 1997 May 01; 17(5):889-97. PubMed ID: 9157952
    [Abstract] [Full Text] [Related]

  • 8. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
    Nakamuta M, Taniguchi S, Ishida BY, Kobayashi K, Chan L.
    Arterioscler Thromb Vasc Biol; 1998 May 01; 18(5):747-55. PubMed ID: 9598833
    [Abstract] [Full Text] [Related]

  • 9. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
    Oka K, Pastore L, Kim IH, Merched A, Nomura S, Lee HJ, Merched-Sauvage M, Arden-Riley C, Lee B, Finegold M, Beaudet A, Chan L.
    Circulation; 2001 Mar 06; 103(9):1274-81. PubMed ID: 11238273
    [Abstract] [Full Text] [Related]

  • 10. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.
    Oka K, Mullins CE, Kushwaha RS, Leen AM, Chan L.
    Gene Ther; 2015 Jan 06; 22(1):87-95. PubMed ID: 25231173
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y, Liu XQ, Rall SC, Mahley RW.
    J Biol Chem; 1998 Jul 10; 273(28):17483-90. PubMed ID: 9651338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A, Kan HY, Shkodrani A, Liu T, Zannis VI.
    Biochemistry; 2005 Mar 15; 44(10):4108-17. PubMed ID: 15751988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L.
    Circulation; 2003 Jun 03; 107(21):2726-32. PubMed ID: 12742997
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor.
    Oka K, Ishimura-Oka K, Chu MJ, Sullivan M, Krushkal J, Li WH, Chan L.
    Eur J Biochem; 1994 Sep 15; 224(3):975-82. PubMed ID: 7925422
    [Abstract] [Full Text] [Related]

  • 20. HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice.
    Draijer R, Volger OL, Dahlmans VE, de Wit EC, Havekes LM, Princen HM.
    Biochem Pharmacol; 2002 May 01; 63(9):1755-61. PubMed ID: 12007578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.